Literature DB >> 3326742

Predictive value of surveillance cultures for systemic infection due to Candida species.

M Pfaller1, I Cabezudo, F Koontz, M Bale, R Gingrich.   

Abstract

Weekly fungal surveillance cultures (1,542 cultures) of urine (475), stool (520) and oropharyngeal (547) specimens from 111 patients on the bone marrow transplant and hematologic malignancy services were analyzed. Forty-three percent of the patients were colonized by Candida albicans and 10.8% by Candida tropicalis. There were 22 proven systemic fungal infections, ten due to Candida albicans, eight to Candida tropicalis, one each to Candida pseudotropicalis and Torulopsis glabrata, and two to Aspergillus species. Positive surveillance cultures for Candida tropicalis were highly predictive of systemic infection. The finding of two or more positive cultures yielded high positive predictive values (100%) as a function of body site. Positive surveillance cultures for Candida albicans were not predictive of disease but negative cultures for Candida albicans and Candida tropicalis had a high negative predictive value (95-99%). Surveillance culture data for specific Candida species may aid in diagnostic and therapeutic decision making.

Entities:  

Mesh:

Year:  1987        PMID: 3326742     DOI: 10.1007/bf02013057

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN: 0722-2211            Impact factor:   3.267


  7 in total

1.  Fungal infection and fever of unknown origin in neutropenic patients.

Authors:  G P Bodey
Journal:  Am J Med       Date:  1986-05-30       Impact factor: 4.965

2.  Alimentary tract colonization by Candida albicans.

Authors:  H H Stone; C E Geheber; L D Kolb; W R Kitchens
Journal:  J Surg Res       Date:  1973-04       Impact factor: 2.192

3.  Fungemia in a cancer hospital: changing frequency, earlier onset, and results of therapy.

Authors:  R Horn; B Wong; T E Kiehn; D Armstrong
Journal:  Rev Infect Dis       Date:  1985 Sep-Oct

4.  The value of fungal surveillance cultures as predictors of systemic fungal infections.

Authors:  G R Sandford; W G Merz; J R Wingard; P Charache; R Saral
Journal:  J Infect Dis       Date:  1980-10       Impact factor: 5.226

5.  The prevalence of yeasts in clinical specimens from cancer patients.

Authors:  T E Kiehn; F F Edwards; D Armstrong
Journal:  Am J Clin Pathol       Date:  1980-04       Impact factor: 2.493

6.  Candida tropicalis: a major pathogen in immunocompromised patients.

Authors:  J R Wingard; W G Merz; R Saral
Journal:  Ann Intern Med       Date:  1979-10       Impact factor: 25.391

7.  Pathogenicity of Candida tropicalis and Candida albicans after gastrointestinal inoculation in mice.

Authors:  J R Wingard; J D Dick; W G Merz; G R Sandford; R Saral; W H Burns
Journal:  Infect Immun       Date:  1980-08       Impact factor: 3.441

  7 in total
  15 in total

1.  Diagnosis of disseminated candidiasis in hospitalized patients using the Cand-Tec latex agglutination assay.

Authors:  M L Sanchez; M A Pfaller; I Cabezudo; M Bale; B Buschelman
Journal:  Mycopathologia       Date:  1992-06       Impact factor: 2.574

Review 2.  Epidemiology of invasive candidiasis: a persistent public health problem.

Authors:  M A Pfaller; D J Diekema
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

Review 3.  Infection in the bone marrow transplant recipient and role of the microbiology laboratory in clinical transplantation.

Authors:  M T LaRocco; S J Burgert
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

Review 4.  Updates in Laboratory Diagnostics for Invasive Fungal Infections.

Authors:  David Terrero-Salcedo; Margaret V Powers-Fletcher
Journal:  J Clin Microbiol       Date:  2020-05-26       Impact factor: 5.948

5.  Value of the Cand-Tec Candida antigen assay in the diagnosis and therapy of systemic candidiasis in high-risk patients.

Authors:  I Cabezudo; M Pfaller; T Gerarden; F Koontz; R Wenzel; R Gingrich; K Heckman; C P Burns
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-09       Impact factor: 3.267

Review 6.  Diagnosis of invasive mycoses in severely immunosuppressed patients.

Authors:  R Rüchel
Journal:  Ann Hematol       Date:  1993-07       Impact factor: 3.673

7.  Application of CHROMagar Candida for rapid screening of clinical specimens for Candida albicans, Candida tropicalis, Candida krusei, and Candida (Torulopsis) glabrata.

Authors:  M A Pfaller; A Houston; S Coffmann
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

8.  Elucidating the origins of nosocomial infections with Candida albicans by DNA fingerprinting with the complex probe Ca3.

Authors:  F Marco; S R Lockhart; M A Pfaller; C Pujol; M S Rangel-Frausto; T Wiblin; H M Blumberg; J E Edwards; W Jarvis; L Saiman; J E Patterson; M G Rinaldi; R P Wenzel; D R Soll
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

9.  Comparison of the Quantum II, API Yeast Ident, and AutoMicrobic systems for identification of clinical yeast isolates.

Authors:  M A Pfaller; T Preston; M Bale; F P Koontz; B A Body
Journal:  J Clin Microbiol       Date:  1988-10       Impact factor: 5.948

10.  Candida krusei, a multidrug-resistant opportunistic fungal pathogen: geographic and temporal trends from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005.

Authors:  M A Pfaller; D J Diekema; D L Gibbs; V A Newell; E Nagy; S Dobiasova; M Rinaldi; R Barton; A Veselov
Journal:  J Clin Microbiol       Date:  2007-12-12       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.